Dengue Virus Type 2 (DENV2)-Induced Oxidative Responses in Monocytes from Glucose-6-Phosphate Dehydrogenase (G6PD)-Deficient and G6PD Normal Subjects

PLoS Neglected Tropical Diseases

Volumn 8, Issue 3, 2014, Pages

  Al alimi, Abdullah Ahmed ^a   Ali, Syed A ^a   Al Hassan, Faisal Muti ^a   Idris, Fauziah Mohd ^b   Teow, Sin Yeang ^a   Mohd Yusoff, Narazah ^a  

^a ADVANCED MEDICAL AND DENTAL INSTITUTE   (Malaysia)

^b SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; NITRIC OXIDE; SUPEROXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENGUE VIRUS 2; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; MONOCYTE; OXIDATIVE STRESS; VIRUS CULTURE; VIRUS LOAD; VIRUS REPLICATION; VIRUS TRANSMISSION;

ADULT; CELLS, CULTURED; DENGUE VIRUS; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; GRANULOCYTES; HUMANS; MALAYSIA; MALE; MONOCYTES; NITRIC OXIDE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VIRAL LOAD; VIRUS REPLICATION;

EID: 84897388212     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002711     Document Type: Article

References (35)

1. World Health Organization Impact of Dengue. Global Alert and Response (GAR). http://www.who.int/csr/disease/dengue/impact/en/.
2. Halsey ES, Marks MA, Gotuzzo E, Fiestas V, Suarez L, et al. (2012) Correlation of serotype-specifi18c dengue virus infection with clinical manifestations. PLoS Negl Trop Dis 6: e1638.
3. Rico-Hesse R, (2010) Dengue virus virulence and transmission determinants. Curr Top Microbiol Immunol 338: 45-55.
4. Dias LL, Amarilla AA, Poloni TR, Covas DT, Aquino VH, et al. (2012) Detection of dengue virus in sera of Brazilian blood donors. Transfusion 52: 1667-1671.
5. Prasad N, Bhadauria D, Sharma RK, Gupta A, Kaul A, et al. (2012) Dengue virus infection in renal allograft recipients: a case series during 2010 outbreak. Transpl Infect Dis 14: 163-168.
6. Kalayanarooj S, (2011) Clinical Manifestations and Management of Dengue/DHF/DSS. Trop Med Health 39: 83-87.
7. Marón GM, Clará AW, Diddle JW, Pleités EB, Miller L, et al. (2010) Association between nutritional status and severity of dengue infection in children in El Salvador. Am J Trop Med Hyg 82: 324-329.
8. Boonnak K, Dambach KM, Donofrio GC, Tassaneetrithep B, Marovich MA, (2011) Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection. J Virol 85: 1671-1683.
9. Chao YC, Huang CS, Lee CN, Chang SY, King CC, et al. (2008) Higher infection of dengue virus serotype 2 in human monocytes of patients with G6PD deficiency. PLoS One 13: e1557.
10. Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, et al. (2012) G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med 9 (11) (): e1001339.
11. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E, (2009) The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 42: 267-278.
12. Phompradit P, Kuesap J, Chaijaroenkul W, Rueangweerayut R, Hongkaew Y, et al. (2011) Prevalence and distribution of glucose-6-phosphate dehydrogenase (G6PD) variants in Thai and Burmese populations in malaria endemic areas of Thailand. Malar J 10: 368.
13. Ho HY, Cheng ML, Chiu DT, (2007) Glucose-6-phosphate dehydrogenase-from oxidative stress to cellular functions and degenerative diseases. Redox Rep 3: 109-118.
14. Akaike T, Suga M, Maeda H, (1998) Free radicals in viral pathogenesis: molecular mechanisms involving superoxide and NO. Proc Soc Exp Biol Med 217: 64-73.
15. Tanphaichitr VS, Chonlasin R, Suwantol L, Pung-Amritt P, Tachavanich K, Yogsan S, Viprakasit V, (2002) Effect of red blood cell glucose-6-phosphate dehydrogenase deficiency on patients with dengue hemorrhagic fever. J Med Assoc Thai 85 (Suppl 2) ():: S522-S529.
16. Roehrig JT, Hombach J, Barrett AD, (2008) Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses. Viral Immunol 21: 123-32.
17. Chen TP, Roberts RL, Wu KG, Ank BJ, Stiehm ER, (1993) Decreased superoxide anion and hydrogen peroxide production by neutrophils and monocytes in human immunodeficiency virus-infected children and adults. Pediatr Res 34: 544-550.
18. Abu-Osba YK, Mallouh AA, Hann RW, (1989) Incidence and causes of sepsis in glucose-6-phosphate dehydrogenase-deficient newborn infants. J Pediatr 114: 748-752.
19. Costa E, Vasconcelos J, Santos E, Laranjeira A, Castro e Melo, Barbot J, (2002) Neutrophil dysfunction in a case of glucose-6-phosphate dehydrogenase deficiency. J Pediatr Hematol Oncol 24: 164-165.
20. Wu YH, Tseng CP, Cheng ML, Ho HY, Shih SR, et al. (2008) Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection. J Infect Dis 197: 812-816.
21. Biagioli MC, Kaul P, Singh I, Turner RB, (1999) The role of oxidative stress in rhinovirus induced elaboration of IL-8 by respiratory epithelial cells. Free Radic Biol Med 26: 454-462.
22. Cai J, Chen Y, Seth S, Furukawa S, Compans RW, et al. (2003) Inhibition of influenza infection by glutathione. Free Radic Biol Med 34: 928-936.
23. Serpa JA, Villarreal-Williams E, Giordano TP, (2010) Prevalence of G6PD deficiency in a large cohort of HIV-infected patients. J Infect 61: 399-402.
24. Tungsiripat M, Drechsler H, Sarlone C, Amyot K, Laffey E, et al. (2008) Prevalence and significance of G6PD deficiency in patients of an urban HIV clinic. J Int Assoc Physicians AIDS Care 7: 88-90.
25. Ho HY, Cheng ML, Weng SF, Chang L, Yeh TT, et al. (2008) Glucose-6-phosphate dehydrogenase deficiency enhances enterovirus 71 infection. J Gen Virol 89: 2080-2089.
26. Beck MA, Levander OA, Handy J, (2003) Selenium deficiency and viral infection. J Nutr 133: 1463S-7S.
27. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, et al. (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 185: 1213-1221.
28. Wang WK, Chao DY, Kao CL, Wu HC, Liu YC, et al. (2003) High levels of plasma dengue viral load during defervescence in patients with dengue hemorrhagic fever: implications for pathogenesis. Virology 305: 330-338.
29. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, et al. (2004) Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189: 990-1000.
30. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, et al. (2006) Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis 193: 1078-1088.
31. Fox A, Le NM, Simmons CP, Wolbers M, Wertheim HF, et al. (2011) Immunological and viral determinants of dengue severity in hospitalized adults in Ha Noi, Viet Nam. PLoS Negl Trop Dis 5 (3) (): e967.
32. van Bruggen R, Bautista JM, Petropoulou T, de Boer M, van Zwieten R, et al. (2002) Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections. Blood 100 (3) (): 1026-1030.
33. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E, (2009) The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 42 (3) (): 267-278.
34. de la C Sierra B, García G, Pérez AB, Morier L, Alvarez M, Kourí G, Guzmán MG, (2006) Ethnicity and difference in dengue virus-specific memory T cell responses in Cuban individuals. Viral Immunol 19 (4) (): 662-668.
35. de la C Sierra B, Kourí G, Guzmán MG, (2007) Race: a risk factor for dengue hemorrhagic fever. Arch Virol 152 (3) (): 533-542.